Ivetta Danylesko

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Anti-CD19 CAR T-cell therapy as salvage treatment for refractory cutaneous polyarteritis nodosa.

Anti-CD19 CAR T-cell therapy as salvage treatment for refractory cutaneous polyarteritis nodosa.

Journal: Annals of the rheumatic diseases

Published: May 23, 2026

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Journal: Rheumatology (Oxford, England)

Published: November 24, 2025

CAR-T as a salvage treatment in polyrefractory RA.

CAR-T as a salvage treatment in polyrefractory RA.

Journal: Rheumatology (Oxford, England)

Published: November 04, 2025

Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma: a multicenter propensity scorematched analysis.

Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma: a multicenter propensity scorematched analysis.

Journal: Haematologica

Published: June 11, 2025

CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia.

CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia.

Journal: Journal of cellular and molecular medicine

Published: March 29, 2025

Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I/II study.

Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I/II study.

Journal: British journal of haematology

Published: March 08, 2025

Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcome.

Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcome.

Journal: Genome medicine

Published: January 21, 2025

Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cells.

Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cells.

Journal: Blood advances

Published: August 14, 2024

CD-19 CAR-T cells for polyrefractory rheumatoid arthritis.

CD-19 CAR-T cells for polyrefractory rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: July 19, 2024

Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression.

Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression.

Journal: Current research in translational medicine

Published: May 09, 2024

Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma.

Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma.

Journal: Haematologica

Published: November 26, 2023

Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation.

Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation.

Journal: Bone marrow transplantation

Published: October 20, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026